These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35267493)

  • 41. Comprehensive Evaluation of Machine Learning Models and Gene Expression Signatures for Prostate Cancer Prognosis Using Large Population Cohorts.
    Li R; Zhu J; Zhong WD; Jia Z
    Cancer Res; 2022 May; 82(9):1832-1843. PubMed ID: 35358302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of Pan-Cancer Biomarkers Based on the Gene Expression Profiles of Cancer Cell Lines.
    Ding S; Li H; Zhang YH; Zhou X; Feng K; Li Z; Chen L; Huang T; Cai YD
    Front Cell Dev Biol; 2021; 9():781285. PubMed ID: 34917619
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decoding whole-genome mutational signatures in 37 human pan-cancers by denoising sparse autoencoder neural network.
    Pei G; Hu R; Dai Y; Zhao Z; Jia P
    Oncogene; 2020 Jul; 39(27):5031-5041. PubMed ID: 32528130
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mapping Driver Mutations to Histopathological Subtypes in Papillary Thyroid Carcinoma: Applying a Deep Convolutional Neural Network.
    Tsou P; Wu CJ
    J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31614962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?
    Tonella L; Giannoccaro M; Alfieri S; Canevari S; De Cecco L
    Curr Treat Options Oncol; 2017 May; 18(5):32. PubMed ID: 28474265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA based Pan-Cancer Diagnosis and Treatment Recommendation.
    Cheerla N; Gevaert O
    BMC Bioinformatics; 2017 Jan; 18(1):32. PubMed ID: 28086747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pan-cancer integrative analysis of whole-genome De novo somatic point mutations reveals 17 cancer types.
    Ghareyazi A; Kazemi A; Hamidieh K; Dashti H; Tahaei MS; Rabiee HR; Alinejad-Rokny H; Dehzangi I
    BMC Bioinformatics; 2022 Jul; 23(1):298. PubMed ID: 35879674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DeepCIA: a novel deep-learning model for cancer type identification using class activation map via transcription factor expression.
    Jeong S; Lee D; Park HR; Kang J; Yu Y; Hwang JJ; Kim YH
    Am J Cancer Res; 2022; 12(12):5631-5645. PubMed ID: 36628273
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tree-based machine learning algorithms identified minimal set of miRNA biomarkers for breast cancer diagnosis and molecular subtyping.
    Sherafatian M
    Gene; 2018 Nov; 677():111-118. PubMed ID: 30055304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Neural Network Framework for Predicting the Tissue-of-Origin of 15 Common Cancer Types Based on RNA-Seq Data.
    He B; Zhang Y; Zhou Z; Wang B; Liang Y; Lang J; Lin H; Bing P; Yu L; Sun D; Luo H; Yang J; Tian G
    Front Bioeng Biotechnol; 2020; 8():737. PubMed ID: 32850691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identifying cancer tissue-of-origin by a novel machine learning method based on expression quantitative trait loci.
    Miao Y; Zhang X; Chen S; Zhou W; Xu D; Shi X; Li J; Tu J; Yuan X; Lv K; Tian G
    Front Oncol; 2022; 12():946552. PubMed ID: 36016607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The
    Ibrahim J; Op de Beeck K; Fransen E; Peeters M; Van Camp G
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31752152
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Somatic gene mutation signatures predict cancer type and prognosis in multiple cancers with pan-cancer 1000 gene panel.
    Wang HL; Liu PF; Yue J; Jiang WH; Cui YL; Ren H; Wang H; Zhuang Y; Liu Y; Jiang D; Dong Q; Zhang H; Mi JH; Xu ZM; Tian CJ; Zhang ZZ; Wang XW; Su MN; Lu W
    Cancer Lett; 2020 Feb; 470():181-190. PubMed ID: 31765737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers.
    Kandimalla R; Xu J; Link A; Matsuyama T; Yamamura K; Parker MI; Uetake H; Balaguer F; Borazanci E; Tsai S; Evans D; Meltzer SJ; Baba H; Brand R; Von Hoff D; Li W; Goel A
    Clin Cancer Res; 2021 Nov; 27(22):6135-6144. PubMed ID: 34465601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular analysis of TCGA breast cancer histologic types.
    Thennavan A; Beca F; Xia Y; Recio SG; Allison K; Collins LC; Tse GM; Chen YY; Schnitt SJ; Hoadley KA; Beck A; Perou CM
    Cell Genom; 2021 Dec; 1(3):. PubMed ID: 35465400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
    Glinsky GV
    Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multi-Run Concrete Autoencoder to Identify Prognostic lncRNAs for 12 Cancers.
    Al Mamun A; Tanvir RB; Sobhan M; Mathee K; Narasimhan G; Holt GE; Mondal AM
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distinct signatures of codon and codon pair usage in 32 primary tumor types in the novel database CancerCoCoPUTs for cancer-specific codon usage.
    Meyer D; Kames J; Bar H; Komar AA; Alexaki A; Ibla J; Hunt RC; Santana-Quintero LV; Golikov A; DiCuccio M; Kimchi-Sarfaty C
    Genome Med; 2021 Jul; 13(1):122. PubMed ID: 34321100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pan-cancer survey of epithelial-mesenchymal transition markers across the Cancer Genome Atlas.
    Gibbons DL; Creighton CJ
    Dev Dyn; 2018 Mar; 247(3):555-564. PubMed ID: 28073171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.